Congenital valvular anomalies include developmental abnormalities of the heart valves and their supporting structures. They may alter leaflet number, consistency and mobility, commissural arrangement, annular size, or the organization of chordae and papillary muscles. The anatomical defect is present from birth, but dysfunction may become apparent during fetal life, in the first months, or many years later. Diagnosis in adulthood therefore does not exclude congenital origin.
The significance of a malformation depends on the relationship between anatomy and function. An unusual valve may provide adequate flow for decades; a less conspicuous deformity may impede filling or ejection and affect the development of cardiac chambers. Understanding the disease requires describing both structure and hemodynamic consequences and relating them to age, growth, and any associated heart defects. The name of a variant alone is not an indication for treatment.
These conditions require a lifespan perspective. Pediatric cardiologists assess the heart's ability to support growth; adult congenital heart disease specialists monitor progression of the defect and previous interventions; the valve team determines repair or replacement options. Continuity among these specialties is part of treatment because a decision made in childhood can affect the options available many years later.
Valvulogenesis results from coordinated processes of formation and remodeling of embryonic cardiac tissues. Initially thicker structures become thin, mobile leaflets that can open with little resistance and close without significant leakage. In the atrioventricular valves, maturation also entails separation and organization of connections to the ventricular myocardium. Disturbances in these processes may affect several components simultaneously, making a description limited to the leaflet inadequate.
The term dysplasia describes abnormal valve tissue organization, often with thickened, poorly mobile leaflets. It does not necessarily mean stenosis: dysplastic leaflets may open poorly, close poorly, or have both defects. Similarly, a small annulus has different implications depending on body surface area and ventricular size. In children, absolute dimensions must be compared with body-size-adjusted references; an isolated measurement does not describe the adequacy of the entire apparatus.
In semilunar valves, the number of cusps is readily recognizable, but commissural arrangement is equally important. A unicuspid aortic valve may cause early obstruction to ejection, whereas a quadricuspid aortic valve is more often associated with impaired closure. These tendencies do not replace individual assessment: either valve may show different combinations of stenosis and regurgitation.
The mitral valve functions as an integrated assembly of annulus, leaflets, chordae, and papillary muscles. In a parachute mitral valve, chordal insertions converge on a single papillary muscle; in an anomalous mitral arcade, short or direct connections between the papillary apparatus and leaflets are particularly important. Intermediate forms are numerous. A segment-by-segment description therefore retains more information than a single morphological label.
Etiology is often multifactorial. A family history of heart defects, extracardiac abnormalities, or syndromic features may prompt genetic counseling, while many isolated forms remain without an identified molecular cause. The rarity of a variant does not automatically imply an inherited syndrome. Assessment should distinguish documented associations from hypotheses and consider whether genetic findings would alter surveillance for the patient or family members.
Stenosis forces blood through an opening too small for the required flow. In outflow valves it increases the pressure work of the ejecting ventricle; in atrioventricular valves it obstructs filling and raises upstream pressure. The consequences are not interchangeable: aortic obstruction initially affects left ventricular loading, whereas congenital mitral stenosis primarily affects left atrial pressure and the pulmonary circulation.
Regurgitation causes blood to flow backward through a valve that should be closed. The ventricle may compensate by increasing the volume ejected, but some of this volume does not contribute to effective forward output. In chronic disease, chamber dilation initially helps maintain performance; over time it may indicate an overload that is no longer well tolerated. An apparently normal ejection fraction does not always demonstrate absence of injury because it also depends on loading conditions.
Congenital mitral regurgitation illustrates the connection between mechanism and treatment. Failure of closure may result from insufficient leaflet tissue, restriction, prolapse, or abnormal chordal connections. A leaflet cleft, as in a mitral cleft, requires different reasoning from a diffusely dysplastic valve. The same degree of regurgitation therefore does not mean the same reparability.
Mixed lesions combine obstruction and leakage. Regurgitation increases the volume crossing the valve and may raise Doppler velocities, while reduced output may attenuate the gradient of significant stenosis. A number interpreted without context may therefore overestimate or underestimate severity. Assessment must integrate anatomical orifice, flows, chamber size and function, blood pressure, and clinical conditions at the time of examination.
During growth, an effective repair or an initially adequate opening may become relatively restrictive as demands increase. Conversely, some native structures may grow after blood flow improves. In complex defects, the outcome depends on the balance of the entire circulation: correcting a valve without identifying an obstruction elsewhere may leave a significant residual load. This interdependence explains the need to examine the outflow tracts, aortic arch, and vascular connections as well.
Fetal presentation may be dominated by the consequences of dysfunction rather than precise morphological definition. A severely obstructed valve may be associated with asymmetric chamber growth and abnormal flow; substantial regurgitation may cause dilation and hemodynamic compromise. Fetal echocardiography helps characterize progression, detect associated abnormalities, and organize care at birth. Reassuring prenatal findings do not exclude every mild variant or lesions that become more evident later.
In the newborn, feeding difficulties, tachypnea, poor perfusion, and reduced responsiveness may indicate significant heart disease. Critical outflow obstructions may deteriorate as the ductus arteriosus closes and require urgent assessment in a specialist setting. Peripheral oxygen saturation may remain relatively preserved in some left-sided lesions: a normal value does not negate signs of low output or congestion. Clinical assessment remains essential alongside instrument-based screening.
In children, poor growth and reduced endurance during play may precede a clear description of symptoms. Children may adapt by spontaneously avoiding strenuous activity without reporting breathlessness. Discussion with the family and, when appropriate, objective assessment of exercise capacity help reveal this limitation. Symptom onset must be interpreted alongside trends in echocardiographic measurements, rather than using school or sports performance alone as a criterion of severity.
In adults, suspicion may arise from a murmur, a test performed for another reason, or dyspnea, palpitations, and reduced exercise tolerance. A late diagnosis warrants investigation of previous interventions, old medical reports, and signs of associated heart defects. A congenital abnormality may coexist with hypertension, coronary artery disease, or respiratory disorders; attributing every complaint to the valve without verifying the mechanism may lead to inappropriate treatment decisions.
Auscultation offers clues to the type of abnormal flow, but murmur intensity does not consistently correspond to severity. A severely dysfunctional valve with low flow may produce only a modest finding. Examination includes blood pressure, pulses, congestion, perfusion, and any physical features suggestive of a syndrome. Electrocardiography adds information on rhythm, conduction, and possible signs of overload but cannot rule out a malformation when normal.
Echocardiography is the initial test because it allows observation of valve motion and its relation to blood flow. Assessment should document leaflet number and mobility, commissures, annulus, and subvalvular structures, as well as the chambers and other cardiac connections. For atrioventricular valves, three-dimensional reconstruction may clarify spatial relationships but does not replace careful two-dimensional imaging. Image quality determines the reliability of an apparently precise classification.
Doppler quantifies velocities and gradients, identifies regurgitant jets, and contributes to pressure estimation. Measurements must be documented alongside heart rate and hemodynamic conditions. The mitral gradient rises with tachycardia and flow; the aortic gradient may decrease when the ventricle does not generate adequate flow. When monitoring progression, comparisons are more informative if acquisitions are technically consistent and loading differences are recognized.
Evaluation of regurgitation must combine several signs. Apparent jet size, vena contracta, Doppler features, and chamber responses provide complementary information; an eccentric wall-hugging jet may appear smaller than the actual leak would suggest. Some quantitative methods rely on geometric assumptions that become less reliable with irregular congenital valves. When measurements and clinical findings disagree, the discrepancy must be resolved rather than simply choosing the most reassuring value.
Cardiac magnetic resonance helps measure volumes, function, and flows when echocardiography is incomplete or discordant. Computed tomography accurately depicts calcifications, the aortic root, coronary arteries, and spatial relationships, particularly for procedural planning. Modality selection must address a specific question and consider age, need for sedation, radiation, and contrast. Not every patient needs every modality, and repeating tests without a clinical purpose does not automatically improve surveillance.
Cardiac catheterization retains a role when invasive measurements cannot be obtained reliably by other techniques or when intervention is planned. In complex heart defects, it can clarify pressures, flows, and resistance, especially when decisions depend on pulmonary circulation or interactions between multiple obstructions. Invasive assessment should not be performed solely to confirm an already fully defined anatomical diagnosis. Exercise testing must likewise be selected according to age, symptoms, and safety.
Surveillance is an active management choice when function is preserved and significant consequences are absent. The plan must define changes that warrant reassessment: new symptoms, progression of gradient or regurgitation, altered ventricular dimensions, rising pressures, or aortic dilation. Follow-up intervals depend on these factors. A variant's rarity neither justifies indiscriminate preventive intervention nor the absence of organized follow-up.
Medical treatment may reduce congestion, treat hypertension, and control some arrhythmias, but it does not normalize malformed anatomy. In children with growth difficulties, nutritional support is part of treatment and may improve readiness for an intervention. Symptomatic benefit does not prove that obstruction has resolved. If substantial hemodynamic consequences persist, medication response must inform decision-making without becoming a reason to postpone correction indefinitely.
Transcatheter procedures are effective in selected anatomies, but their applicability differs among valves. Balloon dilation may improve commissural obstruction; it does not necessarily resolve a complex deformity of the mitral apparatus and may cause regurgitation. Patient selection must consider the expected result and options for managing complications. A technique established for acquired disease is not necessarily effective for congenital malformations.
Surgical repair seeks to preserve native tissue and function by correcting the mechanism responsible for the defect. This is especially valuable in children, in whom a prosthesis does not grow with the body. Reparability depends on tissue quantity and quality, geometry, and center expertise. Even successful surgery may require subsequent revision: potential reintervention should be discussed as part of a long-term strategy.
Decisions must also consider the quality of the residual result. A preserved but severely regurgitant valve does not necessarily offer an advantage over well-planned replacement; conversely, a limited residual defect may be acceptable if it permits growth and good function. Shared decision-making takes into account expected durability, the number of future procedures, and the patient's informed preferences. Center experience should be assessed in relation to the specific technique proposed, not merely the overall volume of valve operations.
Valve replacement is necessary when repair cannot provide adequate or sufficiently durable function. Choosing among mechanical, biological, and other available options in selected positions requires consideration of anticoagulation, growth, expected durability, pregnancy, and future procedures. Adult valve guidelines provide a decision-making framework that must be integrated with congenital anatomy. Counseling should explain the trade-offs between options rather than presenting a prosthesis as a definitive solution that needs no monitoring.
After treatment, assessment distinguishes the immediate result from its evolution. Residual gradients and regurgitation, ventricular function, pressures, and associated structures must be documented. A moderate gradient may have different meanings depending on the type of repair or prosthesis; a new change from baseline may be more important than comparison with a generic threshold. Monitoring remains valuable even when the patient feels well.
Physical activity should be tailored to valve dysfunction, exercise response, and complications rather than prohibited on the basis of diagnosis alone. A mildly abnormal valve may allow a highly active life, while significant stenosis, ventricular dysfunction, arrhythmias, or aortopathy warrant greater caution and specialist evaluation. Competitive sport requires attention to intensity, static exertion, and traumatic risk for patients on anticoagulants. Advice should be reassessed if the clinical condition changes.
Pregnancy requires preconception assessment. Increased cardiac output and heart rate can make a previously well-tolerated stenosis symptomatic; mechanical valves introduce specific anticoagulation challenges. Ventricular function, pulmonary pressures, and aortic dimensions must also be assessed. Management involves specialist cardiology and obstetric teams and extends into the postpartum period, when rapid volume shifts may alter hemodynamic balance.
Prevention of endocarditis is based on oral hygiene, regular dental care, and prompt recognition of infections. Merely having a congenitally abnormal native valve does not automatically require antibiotic prophylaxis for every procedure. Indications depend on guideline-defined risk groups and procedure types, with particular attention to prostheses, repair material, and previous endocarditis. Persistent unexplained fever in a patient with valve disease requires appropriate investigation.
Transition to adult care must transfer a clear clinical history: initial anatomy, procedures, implanted materials, complications, reference examinations, and follow-up goals. Patients should understand their defect, medications, and warning signs warranting earlier contact. This knowledge supports participation in decisions without defining the person by their heart disease. Continuous management promotes autonomy, employment, physical activity, and family planning, while preserving the opportunity to intervene when needed.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.